PrEP Affect Regulation Treatment Innovation

NCT04899024 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

239

Enrollment

OTHER

Sponsor class

Conditions

Medication Adherence
HIV Prevention
Stimulant Use

Interventions

BEHAVIORAL: PARTI
BEHAVIORAL: Attention-Control
BEHAVIORAL: Contingency Management for PrEP Adherence

Sponsor

Florida International University

Collaborators

[object Object]
[object Object]